pilot study of pembrolizumab plus exemestane/leuprolide for premenopausal metastatic breast cancer
Published 3 years ago • 37 plays • Length 4:30Download video MP4
Download video MP3
Similar videos
-
3:27
alpelisib plus fulvestrant for hormone receptor positive metastatic breast cancer
-
2:55
outcomes with pembrolizumab monotherapy among patients with pd-l1 positive lung cancer and brain me
-
3:02
neoadjuvant alpelisib plus nab-paclitaxel for triple-negative breast cancer
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
6:08
management of metastatic lobular breast cancer q&a | lobular breast cancer event
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
1:47
can we decrease chemotherapy in ln premenopausal women based on genomic tests?
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
2:44
leap-015: lenvatinib pembrolizumab mfolfox6 in advanced/met gastroesophageal adenocarcinoma
-
2:54
panacea trial and implications for pembrolizumab use in breast cancer
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
6:50
pd-1 inhibitors for advanced gastroesophageal cancer
-
3:51
achieving a higher pcr rate with nab-paclitaxel in breast cancer
-
2:47
attraction-4: nivolumab plus chemotherapy for gastric or gastroesophageal cancer
-
1:24
dr. jeffrey infante on the positive results of using avelumab in patients with ovarian cancer
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577